Cambridge, Massachusetts, United States In 1992 was created Bluebird Bio, which is appeared as Corporate Investor. The fund was located in North America if to be more exact in United States. The leading representative office of defined Corporate Investor is situated in the Cambridge.
Besides, a startup requires to be at the age of 4-5 years to receive the investment from the fund. Among the most successful fund investment fields, there are Biotechnology, Health Care. Among the most popular portfolio startups of the fund, we may highlight TC BioPharm. For fund there is no match between the country of its foundation and the country of its the most frequent investments - United Kingdom.
This organization was formed by Philippe Leboulch.
The typical case for the fund is to invest in rounds with 1 participant. Despite the Bluebird Bio, startups are often financed by Scottish Investment Bank, Renaissance Capital Partners, Nipro Corporation. In the next rounds fund is usually obtained by Scottish Enterprise, Renaissance Capital Partners.
The common things for fund are deals in the range of 10 - 50 millions dollars. The high activity for fund was in 2017. The fund is generally included in less than 2 deals every year.
Related Funds
| Fund Name | Location |
| APICIL Group | Caluire-et-cuire, France, Rhone-Alpes |
| Business Angels Club Berlin | Berlin, Berlin, Germany |
| BUYOVERCHAT TECHNOLOGIES LIMITED | Lagos, Lagos, Nigeria |
| Clarion Capital Partners | New York, New York, United States |
| EFung Capital | China, Guangdong, Shenzhen |
| Jiangxi Bokan Touzi | China, Guangdong, Jiangxi |
| Lean Bricks Ventures | - |
| Pushtech Technologies | - |
| QD Ventures | Castel, Guernsey, Guernsey |
| S5 Partners | Japan, Tokyo |
| Shangchengqu Venture Capital | China, Hangzhou, Zhejiang |
| Shanghai Yongquan Yixin Investment Development Center | China, Shanghai |
| Sunflower Development Group | - |
| WaterEquity | Kansas City, Missouri, United States |
| Wishcompany | Seoul, Seoul-t'ukpyolsi, South Korea |
| Zhangwo Keji | Binhai, China, Jiangsu |
| Zhixing Venture Capital | - |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
TC BioPharm | $16M | 07 Dec 2017 | Scotland |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
TC BioPharm | $16M | 07 Dec 2017 | Scotland |
